• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Omega Therapeutics, Inc. - Common Stock (NQ: OMGA )

    0.8322 +0.0212 (+2.61%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Omega Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts
    Via Benzinga
    Uber To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q2 2024
    OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Expert Ratings For Omega Therapeutics
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    4 Analysts Have This To Say About Omega Therapeutics
    Via Benzinga
    How Is The Market Feeling About Omega Therapeutics?
    Via Benzinga
    OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024
    OMGA stock results show that Omega Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023
    OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    The 3 Best Biotech Stocks to Buy in January 2024
    Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks. 
    Via InvestorPlace
    Nvidia, Spotify Lead Five Stocks Near Buy Points
    Nvidia could make some noise with its CES presentation Monday. 
    Via Investor's Business Daily
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Applied Therapeutics, Inc. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review
    Tesla, Apple and Mobileye were key losers. 
    Via Investor's Business Daily
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
    Via Benzinga
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
    Via Investor's Business Daily
    Why Novo Nordisk Stock Crushed the Market Today
    The company just boosted its research and development efforts. 
    Via The Motley Fool
    Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
    U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Dow Surges 200 Points; US Services PMI Edges Higher In December
    U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10.... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases
    Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc. 
    Via Benzinga
    Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Mixed; Jobless Claims Fall To 202,000
    U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 37,487.49 while the NASDAQ fell... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Novo Nordisk, The Weight-Loss Kingpin, Inks Two New Obesity Deals
    Shares of one new partner nearly doubled after Novo Nordisk pledged to pay up to $532 million. 
    Via Investor's Business Daily
    Can TikTok Save Peloton (PTON) Stock?
    Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok. 
    Via InvestorPlace
    Why Is Evotec (EVO) Stock Down 12% Today?
    Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler. 
    Via InvestorPlace
    Why Is Sellas Life Sciences (SLS) Stock Down 25% Today?
    Sellas Life Sciences stock is sliding lower on Thursday after the company announced a proposed public offering for shares of SLS. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.